DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

DRG Oncology Pulse

Stay on top of updates and innovations in the oncology landscape and how it impacts your decisions

Clinical Development Strategies for Checkpoint Inhibitors

View more

The Biosimilars Games: Who is Doing What and How in the Biosimilars Battlefield?

View more

Treatment Sequencing: Navigating the Complex System of Oncology Pathways

View more
Ask us your question

How are NSCLC Treatments Sequenced and What Factors Drive Prescribing?

View more
Ask us your question

Oncology Clinical Trial Monitor

View more

What is the U.S. Medical Community's Perception About CAR T-cell Therapies?

View more

EHA 2018: Shifting Paradigms in NHL

View more

ASCO Highlights and Industry Implications

View more

Avastin’s FDA Approval in First-line Ovarian Cancer

View more